TechGuru , I just noticed this Q you send to me yesterday ?

By now everyone here knows how I feel about Leronlimab , since years , and every month I am more enthusiastic ...

I too believe that at least with one indication we should go for BO or some type of partnership , HIV could be it..

I be happy with any good BP , but my first choice is Pfizer , because they doing the most research in CCR5 ...

And IMO any company having Leronlimab will leave other BP far in the back with HIV.
There will be no competition , at least not now ...

And I believe that our PrEP will be giant , probably starting sometimes next year..

At this point company will have money and they have time to decide how to approach cancers .


IMO as always.